Tarilian Laser Technologies (TLT) and its product ViCardio®, its world’s first wearable, beat to beat, non-invasive, accurate, blood pressure monitor will be exhibiting at MEDICA 2018, the leading trade fair for the Medical Sector from November 12-15th 2018 at the Hall 15 in the Messe Düsseldorf in Düsseldorf, Germany.
MEDICA is the largest medical trade fair in the world. For more than 40 years, leading individuals from the fields of business, research, and experts from the medical sector gather together to share the latest innovations for outpatients and clinical care. The fair is divided into 5 mains thematic, including Information and Communication Technology, where TLT will be showcasing ViCardio.
In the Hall 15 of the fair, among other world leading innovations in ehealth and mHealth, TLT will be exhibiting its unique and powerful wearable blood pressure monitor and offering demonstrations of its unique micro-motion opto-electronic sensor technology.
“We are delighted to be exhibiting our revolutionary wearable blood pressure monitor at MEDICA 2018. Wearable devices are playing an increasing role in allowing patients to take control of their own health and being present in MEDICA is a great opportunity for the entire global community to see and understand the power of the TLT ViCardio impotence help technology” said Dr Sandeep Shah, CEO of Tarilian Laser Technologies and ViCardio.
Dr Sandeep Shah, CEO of TLT and ViCardio will be introducing ViCardio device at the MEDICA Connected Healthcare Forum on Monday, 12th of November at a keynote address at 11:50 AM.
The ViCardio device is currently being submitted for European CE mark clearance and FDA Approval. The first thousand devices will be available for online purchase in approximately Q1 2018, following CE marking clearance. Further information about the Company and Technology is available at www.vicardio.com
ViCardio was setup as a commercialisation company by Tarilian Laser Technologies (TLT) in early 2018 with the mission to improve the diagnosis, monitoring and control of blood pressure in the community. ViCardio’s first consumer product is TLT’s first wearable blood pressure monitor, powered by TLT’s proprietary optical-electronic micro-motion sensor that allows blood pressure to be measured with each beat of the heart using a simple and elegant wrist-based wearable. For more information, visit www.vicardio.com and www.tarilian.co.uk
For more information or if interested in setting up a meeting please contact:
Dr Sandeep Shah, CEO of TLT and ViCardio:
Mobile: +447768 552 224.
Laura Garcia, ViCardio Marketing Executive:
Mobile: +44 7597717203